Synergism effects of ursolic acid supplementation on the levels of irisin, C-reactive protein, IL-6, and TNF- α during high-intensity resistance training in low activity men.

Synergism effects of ursolic acid supplementation on the levels of irisin, C-reactive protein, IL-6, and TNF-α during high-intensity resistance training in low activity men. Cardiovasc Hematol Disord Drug Targets. 2019 Sep 18;: Authors: Asghari E, Rashidlamir A, Hosseini SRA, Moazzami M, Samarghandian S, Farkhondeh T Abstract BACKGROUND: Ursolic acid (UA) is a pentacyclic triterpenoid carboxylic acid which extracted from plants. UA may enhance the effect of resistance training (RT) in human. OBJECTIVE: Current research was designed to show the effect of high-intensity resistance training (HIRT) in the presence or absence of UA on the serum levels of irisin, CRP, IL-6, and TNF-α in the low activity men. METHOD: Twenty-two healthy male HIRT with placebo, supplementation, and HIRT in presence of UA supplementation. The two groups received eight-week intervention including of 2 sets of 8 exercises, with 8∼10 repetitions at 70∼75% of 1 repetition maximum and a 2 min rest interval between sets, performed 3 times/week. Placebo or UA orally was evaluated as 1 capsule 3 times/day during 8 weeks. The subsequent factors were measured post- and pre-intervention: C-reactive protein (CRP), irisin, tumor necrotic factor (TNF-α) and interleukin-6 (IL-6). RESULTS: UA supplementation significantly increased the plasma levels of irisin in the HIRT+UA group versus the HIRT+P group (p
Source: Cardiovascular and Hematological Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Cardiovasc Hematol Disord Drug Targets Source Type: research

Related Links:

Publication date: Available online 10 November 2019Source: Urology Case ReportsAuthor(s): Jonathan Kopel, Pranav Sharma, Irfan WarriachAbstractSolitary fibrous tumors (SFTs) are rare mesenchymal neoplasms found areas lining the pleura. First reported in 1931, there have been a total of 55 cases of SFTs of the kidney worldwide. In most cases, SFTs presents with hematuria, flank pain, and enlarging abdominal mass. In this case, we report a case of a patient who underwent a radical nephrectomy to remove an SFTs of the kidney with compression of the vena cava. This case further expands upon the importance of diagnosing and ass...
Source: Urology Case Reports - Category: Urology & Nephrology Source Type: research
AbstractHyperlipidemia and oxidative stress are indispensable features of chronic kidney disease (CKD) that favor the development of atherogenic plaques and cardiovascular disease (CVD). A number of vasoactive mediators including proprotein convertase subtilisin –kexin type 9 (PCSK9), endothelin-1, nitric oxide, and angiotensin II have fundamental roles in the pathophysiology of atherosclerotic events; moreover, their levels are affected by dyslipidemia and oxidative stress due to renal dysfunction. Therefore, therapeutic measures aimed at correcting dysl ipidemia and alleviating oxidative stress could potentially pr...
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
AbstractThe prevalence of asymptomatic HUA is increasing year after year. HUA is a risk factor for the occurrence and development of renal diseases. However, the role of urate-lowering therapy in asymptomatic HUA complicated by renal damage is still controversial. In some experiments, the treatment of asymptomatic HUA complicated by renal damage may delay the progression of kidney damage. In addition, there is increasing evidence, suggesting that elevated serum uric acid is an independent risk factor for kidney disease. However, in other studies, uric acid-lowering therapy did not improve renal function, and uric acid leve...
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
ConclusionsTrimetazidine did not exert significant renal protective effect on preventing CIN and in hosptial  major adverse clinical events in unselected patients undergoing PCI.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
ConclusionsUnmarried men are at higher risk of not benefiting of cytoreductive nephrectomy, metastasectomy, or systemic therapy than their married counterparts. Unmarried women are at higher risk of not benefiting of cytoreductive nephrectomy or systemic therapy. These gender-related differences cumulate in higher CSM in unmarried men, but not in unmarried women.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
We examined the relationship between baseline MetS and renal dysfunction after a 3-year evaluation based on estimated glomerul ar filtration rate (eGFRCKDEPI) using the CKD-EPI equations modified by the Japan coefficient. CKD was defined as dipstick-positive proteinuria (>  or = 1 +) or a low eGFRCKDEPI (
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
ConclusionsFebuxostat presents a superior effect in delaying renal impairment progression compared with allopurinol in CKD patients complicated with HUA.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
AbstractKidney injury molecule-1 (KIM-1) staining has been shown to be very useful in identifying acute proximal tubular injury, but its sensitivity, specificity and predicting values for the recovery of renal function after injury in renal biopsies have not been well established. In the first study, we randomly selected 184 renal biopsies from a wide age range of patients (children to elderly) with various renal diseases. KIM-1 staining scores were significantly correlated with serum creatinine (sCr) levels (P 
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
ConclusionIn renal cell carcinoma, rapid and successful drug development has resulted in multiple treatment options, requiring careful decision making for individual patients and have emphasized how newly developed therapies work.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
Marc Rodwin of Suffolk University Law School reports that the French health system controls drug prices by determining maximum prices based on added therapeutic value and external reference pricing; employing negotiation to set prices and limit price increases; and capping total spending to a global budget.        
Source: The Commonwealth Fund: Publications - Category: International Medicine & Public Health Authors: Source Type: research
More News: Cardiology | Cardiovascular | Chemistry | Drugs & Pharmacology | Heart | Hematology | Training | Universities & Medical Training